Prevalence of hepatitis B in pregnant women and management of babies born to Hepatitis B positive mother: A criterion based clinical audit by Singh, Alka et al.
 









ISSN: 2091-2749 (Print) 
          2091-2757 (Online) 
 
 
            
  
Correspondence 
Dr. Alka Singh 
Associate Professor, Department 
of Obstetrics and Gynaecology, 




Peer Reviewed By 
Dr. Jay N Shah 
Patan Academy of Health 
Sciences 
Peer Reviewed By 
Dr. Ashis Shrestha 
Patan Academy of Health 
Sciences 
Prevalence of hepatitis B in pregnant 
women and management of babies born 
to Hepatitis B positive mother: A 
criterion based clinical audit 
Alka Singh,1 Suchita Joshi,2 Yubaraj Sharma,3  
 
1Associate Professor, Department of Obstetrics and Gynaecology,       
2 Assistant Professor, Department of Pediatrics, 3Associate Professor, 




Introductions: This study aims at identifying the prevalence of 
Hepatitis B virus infection in pregnant women and adherence to the 
management of the newborns of these women as per the 
international guidelines. 
 
Methods: This is a cross sectional study conducted at Patan Hospital 
from January 1, 2008 to December 30, 2014. Prevalence of HBsAg in 
pregnant women in Patan Hospital and management of babies born 
to these women, the immunization status, breast feeding status and 
follow up advise for the babies were studied.  These data were 
analyzed to see whether we were following international guidelines 
for preventing mother to child transmission of hepatitis B infection. 
 
Results: There were total of 58,917 deliveries and 59,438 births 
during the seven year study period. During this period, total 148 
cases of pregnant ladies with HBsAg positive status were recorded. 
The prevalence of HBsAg positive case was 0.25% or 1 in every 398 
deliveries. Fifty four babies (87%) received hepatitis B vaccine (HBV) 
and hepatitis B immunoglobulin (HBIG) within 12 hours of birth. 
Eight babies (22%) failed to receive HBV and HBIG within 12hours of 
birth. Fifty eight (96%) babies were breastfed after birth. Mother’s 
HBsAg positive status was not the reason for formula feeding in any 
of the babies. Follow up HBsAg status was not advised in any of the 
babies. 
 
Conclusions: At Patan hospital, we seem to be following most of the 
guidelines in the management of HBV infection, except for checking 
the HBsAg status of the babies at 9-18 months of age.  
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INTRODUCTIONS  
 
Newborn infants acquiring HBV infection by 
perinatal transmission have a greater than 95% 
chance of becoming chronic HBV carriers.1 
Therefore, it is very important to establish 
protocols in institutes to prevent mother to 
child transfer (MTCT) and decrease the burden 
of chronic HBV infection. 
 
Neonates of all HBsAg positive mothers should 
receive immunoprophylaxis treatment with 
HBIG and HBV given within 12 hours of birth to 
decrease MTCT of hepatitis B virus infection.2 
This is 85 to 95 percent effective in reducing 
the infection from vertical transmission.3The 
guidelines also advise to have the HBsAg status 
of the babies checked at 9-18 months of age. 4 
 
The objectives if this study was to audit if the 
recommendation for preventing MTCT of 
hepatitis B and guidelines for babies born to 






This was a cross sectional study done from 
January 1, 2008 to December 30, 2014, 
conducted in Patan Hospital. Delivery record 
files were checked to confirm that HBsAg 
status was recorded in all women. All HBsAg 
positive results of pregnant women recorded 
in the hospital laboratory record book were 
selected. The record files of these patients and 
their babies were retrieved from the record 
filing section. The mode of delivery and 
indication for cesarean sections were noted. 
The immunization status and breast feeding 
status of the babies were also recorded from 
the baby’s hospital record and drug cardex. 
These data were analyzed to see whether we 
were following international guidelines for 
preventing mother to child transmission of 
hepatitis B infection which included 
administration of HBIG and HBV vaccine to the 
neonates of HBsAg-positive mother within 12 
hours of delivery.   
Women who delivered outside Patan Hospital 
and mother or baby’s record file that were 
missing were excluded from this study. 
 
The files were reviewed and the following 
answers were sought for. 
1. Were all pregnant women screened for 
hepatitis B? 
2. Was HBsAg positive status wrongly used 
as an indication for Cesarean section? 
3. Did all babies born to HBsAg positive 
women receive HBV and HBIG within 12 
hours of birth? 
4. Was HBsAg status wrongly used as a 
contraindication for breastfeeding? 
5. Was HBsAg status checked at 9-18 months 






There were total of 58,917 deliveries and 
59,438 births during the seven year study 
period. From the maternity record, it was seen 
that all the women were tested for HBsAg 
before delivery except for five women who 
had no antenatal checkups. 
 
During this period, 148 cases of pregnant 
ladies with HBsAg positive status were 
recorded. The prevalence of HBsAg positive 
case was 0.25% or 1 in every 398 deliveries. 
Among these 148 cases 80(54.1%) cases were 
excluded from the study because their hospital 
records could not be traced.  The reason 
behind not being able to find the hospital 
records among 45 was because they had 
temporary hospital numbers. In our hospital, 
those with temporary numbers are not filed in 
the hospital record section. Among all the 
pregnant ladies with HBsAg positive status, 
68(45.9%) hospital record files were 
successfully traced. Fifteen(22%) of these cases 
had delivery by cesarean section and none of 
them were for HBsAg status. Heptatitis B 
infection was not an indication for cesarean 
section in any of the cases.  The indications 
were: breech(2), meconium(4), failed 
induction(3), previous cesarean with 
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unfavorable cervix(2), cephalopelvic 
disproportion(1) and non progress of labor(3). 
 
Six out of the remaining 68 cases were 
excluded from the study because four babies 
were not delivered in Patan Hospital and 
therefore, they did not have hospital record 
files and two baby records were missing. 
 
Finally, the total cases included in this study 
were 62. The average maternal age was 27 
years. None of the cases were positive for HIV 
and VDRL which is also done routinely for all 
antenatal clients. 
 
The genders of the babies born to these 
mothers, 35(56.4%) were male and 27(43.5%) 
were female. The average gestational age was 
38 weeks (four were premature births).  Fifty 
four(87%) received HBV and HBIG within 12 
hours of birth. Eight babies(22%) failed to 
receive HBV and HBIG within 12hours of birth 
as per the hospital pediatric department 
guidelines. Fifty eight(94%) babies were 
breastfed after birth. Two(3.2%) mothers did 
not breastfeed because the babies were on 
intravenous drip, and the other two mothers 
did not breast feed because they had cesarean 
delivery and felt too weak. Mother’s HBsAg 
positive status was not the reason for formula 
feeding in any of the babies. None of the 
babies were advised to have their HBsAg status 





A hospital based retrospective study was 
carried out. The prevalence of HBsAg positive 
was 0.25% in this study. This is similar to a US 
study, where the prevalence of chronic 
hepatitis B virus infection in pregnancy was 0.2 
to 6%, with rates varying by race and 
ethnicity.5      
 
In Nigeria the incidence of seroprevalence of 
HBsAg was 8.3%6, much higher than ours. The 
CDC recommends that all pregnant women 
should be screened for the presence of HBsAg 
at diagnosis of pregnancy.7 This is also 
supported by U.S. Preventive Services Task 
Force, American Academy of Family Physicians, 
American College of Obstetricians and 
Gynecologists, the American Academy of 
Pediatrics, and the Centers for Disease Control 
and Prevention. Those pregnant women with 
unknown HBsAg status or with risk factors 
should be screened upon admission for 
delivery.8 
 
Although it is recommended that all pregnant 
women should be tested for HBsAg status to 
prevent MTCT of Hepatitis B infection, this is 
not yet practiced in most developing nations 
like Nigeria, hence the high prevalence. In 
developed countries, the increased awareness, 
identification of mothers who are Hepatitis B 
surface antigen and adequate prophylaxis 
reduce the prevalence of HBV infection.9 In a 
large population-based study from Florida 
involving nearly 1.7 million pregnant women, 
the prevalence of HBV was approximately 27 
times higher among Asian-Americans and 5 
times higher among African-Americans as 
compared with whites.10 
 
This emphasizes the importance of screening 
of pregnant women for HBsAg status in our 
country. It was very reassuring to note that in 
Patan Hospital, we have been successful in 
screening all pregnant women for HBsAg 
status. Prevalence rate in this study is 
comparable to western countries and this is 
probably because the antenatal population in 
our hospital is mostly not drug abusers and 
sexual workers and most of their previous 
deliveries were done in hospital setup. 
 
Pregnancy is not a contraindication for 
vaccination to hepatitis B virus.11 Pregnant 
women who are not immune to hepatitis B 
virus should be vaccinated, because premature 
delivery may be increased if acute hepatitis B is 
acquired in the last trimester and because 
MTCT occurs in over 60% of pregnancies 
associated with acute hepatitis B infection at 
or near term.11 Offering HBV during pregnancy 
is not a routine practice in our hospital and this 
can be considered. 
 
Current guidelines do not recommend elective 
cesarean delivery for mothers with chronic 
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HBV infection, since this does not reduce the 
risk of mother to child transmission of HBV. 
Therefore, elective cesarean section should 
not be used in HBsAg positive pregnant 
women to prevent mother to child 
transmission of HBV.12 It was reassuring to 
note that in our hospital, HBsAg positive status 
alone was not being practiced as an indication 
for elective cesarean delivery. 
 
Multiple studies have shown breastfeeding to 
be safe for children with mothers with chronic 
HBV infection.13 The American Academy of 
Pediatrics states that breastfeeding is not 
contra-indicated in women who are HBsAg 
positive.14 Although breast milk contains 
HBsAg, breast feeding does not increase the 
risk of MTCT of hepatitis B virus, especially if 
the baby receives HBV and HBIG within 12 
hours of birth.15 In Patan hospital, we do not 
discourage breast feeding in these mothers 
and this has been reflected in this audit. 
 
HBIG and HBV can effectively prevent mother-
to-child transmission of hepatitis B virus.16 
From this study we can see that in Patan 
Hospital giving HBIG and HBV to babies born to 
HBsAg positive mother is a routine practice. 
Seven babies that missed this were because 
their mother’s HBsAg status was not written in 
neonatal record sheet and one baby was 
discharged before mother’s HbAg test result 
was available. 
 
Unfortunately this study shows that none of 
the babies were advised to have their HBsAg 
status tested at 9-18 months as the guidelines 
suggest. 
 
The limitation of this study was that we were 
unable to trace the record files of those 






We at Patan Hospital seem to be following 
most of the guidelines such as screening all 
women for HBsAg  antenatally, not making 
HBsAg positive an indication for cesarean 
section,  giving HBIG and HBV vaccines before 
12 hours after birth and breastfeeding. But we 
are not checking the HBsAg status of the 
babies at 9-18 months of age as also suggested 
by the guidelines. Therefore, this can be 
introduced in our practice. In order not to miss 
any baby whose mother is HBsAg positive, it 
would be a good idea to have a designated 
space to write the mother’s HBsAg status in 
the neonatal record sheet as we already have 
for the VDRL and HIV status. Besides, the 
junior doctors carrying out newborn 
examination should be trained to check 
maternal notes as well so as not to miss any 
baby who needs HBIG and HBV vaccine. As for 
checking HBsAg and HBAb status of the babies 
at 9-18 months, this is not yet stated in our 
hospital guidelines. As this is now a standard 
recommendation, we should amend this in our 
own guideline and re-audit to see if the 
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